Nautilus Biotechnology, Inc. Variable Lease, Cost
Nautilus Biotechnology, Inc. (NAUT) reported Variable Lease, Cost of $3.41 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-02-26
- Nautilus Biotechnology, Inc. variable lease, cost for the quarter ending 2023-12-31 was $629.00K, a 54.93% increase year-over-year.
- Nautilus Biotechnology, Inc. variable lease, cost for the quarter ending 2023-09-30 was $630.00K, a 46.17% increase year-over-year.
- Nautilus Biotechnology, Inc. variable lease, cost for the quarter ending 2023-06-30 was $638.00K, a 67.89% increase year-over-year.
- Nautilus Biotechnology, Inc. variable lease, cost for the quarter ending 2023-03-31 was $535.00K, a 10600.00% increase year-over-year.
- Nautilus Biotechnology, Inc. variable lease, cost for fiscal 2025 was $3.41M, a 17.46% increase from fiscal 2024.
- Nautilus Biotechnology, Inc. variable lease, cost for fiscal 2024 was $2.90M, a 19.41% increase from fiscal 2023.
- Nautilus Biotechnology, Inc. variable lease, cost for fiscal 2023 was $2.43M, a 46.95% increase from fiscal 2022.
- Nautilus Biotechnology, Inc. variable lease, cost for fiscal 2022 was $1.66M, a 357.18% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 3 month as first filed | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month | Variable Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $3.41M 10-K · filed 2026-02-26 | |||||
| 2024-12-31 | $2.90M 10-K · filed 2026-02-26 | |||||
| 2023-12-31 | $629.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.26M derived: sum of 2 quarters · filed 2025-02-27 | $1.90M derived: sum of 3 quarters · filed 2025-02-27 | $2.43M 10-K · filed 2025-02-27 | ||
| 2023-09-30 | $630.00K 10-Q · filed 2023-10-31 | $1.27M derived: sum of 2 quarters · filed 2023-10-31 | $1.80M 10-Q · filed 2023-10-31 | $2.21M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2023-06-30 | $638.00K 10-Q · filed 2023-08-02 | $1.17M 10-Q · filed 2023-08-02 | $1.58M derived: sum of 3 quarters · filed 2024-02-28 | $2.01M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2023-03-31 | $535.00K 10-Q · filed 2023-05-02 | $941.00K derived: sum of 2 quarters · filed 2024-02-28 | $1.37M derived: sum of 3 quarters · filed 2024-02-28 | $1.75M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-12-31 | $406.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $837.00K derived: sum of 2 quarters · filed 2024-02-28 | $1.22M derived: sum of 3 quarters · filed 2024-02-28 | $1.66M 10-K · filed 2024-02-28 | $25.00K 10-K · filed 2023-02-23 | |
| 2022-09-30 | $431.00K 10-Q · filed 2023-10-31 | $811.00K derived: sum of 2 quarters · filed 2023-10-31 | $1.25M 10-Q · filed 2023-10-31 | $1.15M derived: sum of 4 quarters · filed 2023-10-31 | ||
| 2022-06-30 | $380.00K 10-Q · filed 2023-08-02 | $818.00K 10-Q · filed 2023-08-02 | $720.00K derived: sum of 3 quarters · filed 2023-08-02 | $727.00K derived: sum of 4 quarters · filed 2023-08-02 | ||
| 2022-03-31 | $5.00K 10-Q · filed 2023-05-02 | $438.00K 10-Q · filed 2022-05-03 | $340.00K derived: sum of 2 quarters · filed 2023-05-02 | $347.00K derived: sum of 3 quarters · filed 2023-05-02 | $357.00K derived: sum of 4 quarters · filed 2023-05-02 | |
| 2021-12-31 | $335.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $342.00K derived: sum of 2 quarters · filed 2023-02-23 | $352.00K derived: sum of 3 quarters · filed 2023-02-23 | $362.00K 10-K · filed 2023-02-23 | ||
| 2021-09-30 | $7.00K 10-Q · filed 2022-11-01 | $17.00K derived: sum of 2 quarters · filed 2022-11-01 | $27.00K 10-Q · filed 2022-11-01 | $36.00K derived: sum of 4 quarters · filed 2022-11-01 | ||
| 2021-06-30 | $10.00K 10-Q · filed 2022-08-02 | $20.00K 10-Q · filed 2022-08-02 | $29.00K derived: sum of 3 quarters · filed 2022-08-02 | $39.00K derived: sum of 4 quarters · filed 2022-08-02 | ||
| 2021-03-31 | $10.00K 10-Q · filed 2022-05-03 | $19.00K derived: sum of 2 quarters · filed 2022-05-03 | $29.00K derived: sum of 3 quarters · filed 2022-05-03 | $39.00K derived: sum of 4 quarters · filed 2022-05-03 | ||
| 2020-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $19.00K derived: sum of 2 quarters · filed 2022-02-24 | $29.00K derived: sum of 3 quarters · filed 2022-02-24 | $85.00K 10-K · filed 2022-02-24 | ||
| 2020-09-30 | $10.00K 10-Q · filed 2021-11-02 | $20.00K derived: sum of 2 quarters · filed 2021-11-02 | $76.00K 10-Q · filed 2021-11-02 | |||
| 2020-06-30 | $10.00K 10-Q · filed 2021-08-10 | $66.00K 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |